8-K: i3 Verticals Sells Healthcare RCM Business to Infinx for $96 Million

i3 Verticals divests its Healthcare Revenue Cycle Management (RCM) business to Infinx for $96 million in cash, streamlining its focus on the Public Sector vertical.

Summary

• i3 Verticals, Inc. has completed the sale of its Healthcare Revenue Cycle Management (RCM) business to Infinx, Inc. for $96 million in cash.
• The sale includes the RCM business's associated proprietary technology.
• The purchase price is subject to post-closing net working capital and other purchase price adjustments.
• i3 Verticals will now focus on the Public Sector vertical, including K-12 public education markets.
• The company believes this strategic shift will maximize growth potential and improve customer service.
• Revenues for the RCM Business that was sold represented approximately 83% of our Healthcare Segment revenues for the calendar year 2024.
• Ancillary agreements including a transition services agreement, an employee lease agreement, and a restrictive covenant agreement were entered into at closing.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The company is divesting a business unit to focus on a core area, which is generally viewed favorably. However, the loss of revenue from the divested unit tempers the positive sentiment.

Positives

• The sale provides i3 Verticals with $96 million in cash, which can be used for strategic investments or debt reduction.
• The company can now focus its resources and efforts on its Public Sector vertical, potentially leading to increased growth and efficiency.
• Management believes the streamlined focus will allow them to bring customers the best possible service.
• The transition services agreement should ensure a smooth handover of the RCM business to Infinx.

Negatives

• i3 Verticals is losing a significant portion of its Healthcare Segment revenue (83% for calendar year 2024) with the sale of the RCM business.
• The company is exiting a market that management believes is attractive.
• The purchase price is subject to post-closing adjustments, which could reduce the final amount received.

Risks

• i3 Verticals faces risks associated with executing its strategy and achieving its goals after the completion of the transaction.
• There are risks related to the ancillary agreements, including the transition services agreement, the employee lease agreement, and the restrictive covenant agreement.
• The company's future performance is subject to the risks outlined in its SEC filings, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Future Outlook

i3 Verticals will focus on the Public Sector vertical, including the K-12 public education markets, with the goal of maximizing growth potential and improving customer service. The company anticipates driving innovation and excellence in these sectors.

Management Comments

• Greg Daily, Chairman and CEO of i3 Verticals, stated, 'We are proud of what we built and continue to believe that this is an attractive market. However, we also recognize that scale is important in revenue cycle management, and our future is in providing enterprise software solutions in other markets.'
• Greg Daily also stated, 'After the divestiture, we will be completely streamlined, focused on the Public Sector vertical, including the K-12 public education markets.'
• Jaideep Tandon, Chairman and CEO of Infinx, stated, 'Were thrilled to welcome the i3 Verticals Healthcare RCM team and their customers into the Infinx family.'

Industry Context

The healthcare RCM market is competitive, and scale is considered important. i3 Verticals' decision to divest its RCM business suggests a strategic shift towards markets where it believes it can achieve a stronger competitive position.

Comparison to Industry Standards

• It is difficult to compare this transaction directly to industry standards without knowing the specific financial performance (e.g., revenue, profitability) of the divested RCM business.
• However, similar transactions in the healthcare IT space often involve multiples of revenue or EBITDA, which would provide a benchmark for assessing the value of this deal.
• Companies like R1 RCM, Optum, and Change Healthcare are major players in the RCM market, and their acquisitions or divestitures could provide comparable transactions.
• The focus on AI-powered RCM solutions by Infinx reflects a broader trend in the industry towards automation and data-driven insights.

Stakeholder Impact

• Shareholders: The sale provides cash and allows the company to focus on its core business.
• Employees: Some employees of the RCM business will transition to Infinx.
• Customers: Customers of the RCM business will now be served by Infinx.
• Suppliers: The impact on suppliers is likely to be minimal.

Next Steps

• i3 Verticals will focus on growing its Public Sector vertical.
• Infinx will integrate the acquired RCM business and its team.
• i3 Verticals will provide more detailed information during its quarterly conference call on May 9, 2025.

Key Dates

Keywords

i3 Verticals, Infinx, Healthcare RCM, Revenue Cycle Management, Divestiture, Public Sector, K-12 Education, Acquisition